| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 862.80M | 1.01B | 1.06B | 881.20M | 993.03M |
| Gross Profit | 333.95M | 379.20M | 397.24M | 385.89M | 485.22M |
| EBITDA | 30.82M | 73.22M | 84.95M | 70.14M | 83.53M |
| Net Income | 7.90M | 33.17M | 31.61M | 16.01M | 12.37M |
Balance Sheet | |||||
| Total Assets | 792.80M | 819.55M | 726.39M | 758.58M | 825.43M |
| Cash, Cash Equivalents and Short-Term Investments | 113.18M | 107.10M | 143.48M | 114.97M | 84.27M |
| Total Debt | 245.00M | 162.68M | 145.92M | 172.66M | 200.68M |
| Total Liabilities | 519.18M | 543.27M | 472.61M | 531.07M | 613.93M |
| Stockholders Equity | 273.62M | 276.28M | 253.77M | 227.51M | 211.50M |
Cash Flow | |||||
| Free Cash Flow | -47.74M | -8.47M | 77.79M | 64.47M | 24.30M |
| Operating Cash Flow | 8.49M | 38.19M | 134.07M | 83.23M | 56.58M |
| Investing Cash Flow | -48.34M | -52.50M | -51.61M | -3.69M | -26.99M |
| Financing Cash Flow | 43.37M | -22.45M | -53.93M | -49.12M | -56.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | HK$10.32B | 3.38 | 38.33% | 6.92% | 6.62% | 11.13% | |
78 Outperform | HK$4.14B | 7.17 | 10.39% | 8.21% | 11.68% | 9.03% | |
78 Outperform | HK$49.74B | 10.32 | 21.66% | 6.15% | 5.52% | 3.94% | |
72 Outperform | HK$910.27M | 5.23 | 5.84% | 6.04% | -1.81% | -2.23% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
45 Neutral | HK$76.04M | 10.93 | 2.89% | 12.12% | -14.26% | -76.67% | |
44 Neutral | HK$130.95M | -0.62 | -20.24% | ― | 1.51% | 32.19% |